Effects of benfotiamine on the insulin resistance state, some pro- and anti-inflammatory factors content in patients with type 2 diabetes mellitus and cardiac autonomic neuropathy

Effects of benfotiamine on the insulin resistance state, some pro- and anti-inflammatory factors content in patients with type 2 diabetes mellitus and cardiac autonomic neuropathy

Aim. The aim of the study was to analyze the effect of benfotiamine (BFT) on the insulin resistance state, the content of some pro- and anti-inflammatory factors in patients with type 2 diabetes mellitus (T2DM) and advanced stage of cardiac autonomic neuropathy (CAN).Material and methods. 40 patient...

Full description

Bibliographic Details
Main Authors:	V. A. Serhiyenko, A. A. Serhiyenko, V. B. Segin, S. Azhmi, L. M. Serhiyenko
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2019-05-01
Series:	Российский кардиологический журнал
Subjects:	benfotiamine type 2 diabetes mellitus cardiac autonomic neuropathy insulin resistance pro- and anti-inflammatory factors
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/2997

Similar Items

The potential role of benfotiamine in the treatment of diabetic cardiac autonomic neuropathy
by: V.A. Serhiyenko, et al.
Published: (2020-04-01)

Benfotiamine and Long-Chain Omega-3 and Omega-6 Polyunsaturated Fatty Acids in Treatment of Cardiac Autonomic Neuropathy in Patients with Type 2 Diabetes Mellitus
by: Serhiyenko V., et al.
Published: (2013-09-01)

DIABETES MELLITUS 2ND TYPE WITH CARDIOVASCULAR AUTONOMIC NEUROPATHY
by: V. A. Serhiyenko, et al.
Published: (2015-09-01)

EFFECTS OF OMEGA-3 POLYUNSATURATED FATTY ACIDS ON THE CIRCADIAN RHYTHM OF HEART RATE VARIABILITY PARAMETERS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CARDIOVASCULAR AUTONOMIC NEUROPATHY
by: V. A. Serhiyenko, et al.
Published: (2018-06-01)

Content of Some Pro- and Anti-inflammatory Factors, Insulin Resistance Parameters in Patients with Type 2 Diabetes Mellitus and Cardiovascular Autonomic Neuropathy, Influence of Omega-3 Polyunsaturated Fatty Acids on These Parameters
by: Serhiyenko V., et al.
Published: (2017-09-01)

Effect of alpha-lipoic acid on arterial stiffness parameters in type 2 diabetes mellitus patients with cardiac autonomic neuropathy
by: Serhiyenko Victoria A., et al.
Published: (2021-10-01)

Correlation between arterial wall stiffness, N-terminal prohormone of brain natriuretic peptide, functional and structural myocardial abnormalities in patients with type 2 diabetes mellitus and cardiac autonomic neuropathy
by: Viktoriya Alexandrovna Serhiyenko, et al.
Published: (2013-12-01)

The effect of OMEGA-3 polyunsaturated fatty acids on ambulatory blood pressure monitoring parameters in patients with type 2 diabetes mellitus and cardiovascular autonomic neuropathy
by: Victoria A. Serhiyenko, et al.
Published: (2019-03-01)

Pathophysiological and clinical aspects of the circadian rhythm of arterial stiffness in diabetes mellitus: A minireview
by: Serhiyenko Victoria A., et al.
Published: (2022-10-01)

Thiamine and benfotiamine: Focus on their therapeutic potential
by: Iva Bozic, et al.
Published: (2023-11-01)

Karbon tetraklorür ile oluşturulan deneysel karaciğer hasarında benfotiamin’in karaciğer dokusu üzerine koruyucu etkilerinin incelenmesi
by: Bülent Karakaya, et al.
Published: (2020-06-01)

Accuracy of autonomic symptoms in detection of severe cardiac autonomic neuropathy
by: Tahniyah Haq, et al.
Published: (2022-07-01)

Accuracy of autonomic symptoms in detection of severe cardiac autonomic neuropathy
by: Tahniyah Haq, et al.
Published: (2022-07-01)

Cardiac autonomic neuropathy in patients with diabetes mellitus: current perspectives
by: Fisher VL, et al.
Published: (2017-10-01)

Diabetic polyneuropathy: a current algorithm for patient management
by: L. T. Akhmedzhanova, et al.
Published: (2019-06-01)

Chemoreactomic analysis of thiamine disulfide, thiamine hydrochloride, and benfotiamine molecules
by: O. A. Gromova, et al.
Published: (2017-07-01)

Benfotiamine upregulates antioxidative system in activated BV-2 microglia cells
by: Iva eBozic, et al.
Published: (2015-09-01)

Clinical manifestations and evaluation of cardiac autonomic neuropathy in diabetes mellitus and metabolic syndrome
by: L. S. Moshkhoeva, et al.
Published: (2022-04-01)

Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Benfotiamine in Healthy Subjects
by: Sheng L, et al.
Published: (2021-03-01)

Study of relationship between QTC prolongation and cardiac autonomic neuropathy in Diabetes mellitus
by: N Natarajan1 , M S Ramaiyah2
Published: (2017-12-01)

Cardiac autonomic neuropathy in patients with Type 2 diabetes mellitus at high risk for foot ulcers
by: Anil S Menon, et al.
Published: (2017-01-01)

Serum Metabolomic and Lipidomic Profiling Reveals Novel Biomarkers of Efficacy for Benfotiamine in Alzheimer’s Disease
by: Ruchika Bhawal, et al.
Published: (2021-12-01)

The association between cardiac autonomic neuropathy and diabetes control
by: Vasheghani M, et al.
Published: (2019-04-01)

Optimization of the method for diagnostics of cardial autonomic neuropathy in diabetes mellitus 2 types
by: L. S. Moshkhoeva, et al.
Published: (2021-08-01)

Cardiac Autonomic Neuropathy in Diabetes: A Predictor of Cardiometabolic Events
by: Aaron I. Vinik, et al.
Published: (2018-08-01)

Prevalence of cardiac autonomic neuropathy in patients with type 2 diabetes mellitus
by: Aditya Karthikeyan, et al.
Published: (2023-01-01)

Impaired cardiac structural and functional parameters in patients with chronic heart failure and diabetic cardiac autonomic neuropathy
by: M E Statsenko, et al.
Published: (2013-10-01)

Effect of benfotiamine in podocyte damage induced by peritoneal dialysis fluid
by: Sandra eMüller-Krebs, et al.
Published: (2015-03-01)

Assessment of Diabetic Polyneuropathy and Autonomic Neuropathy Using Current Perception Threshold in Korean Patients with Diabetes Mellitus
by: Bo Kyung Koo, et al.
Published: (2014-08-01)

Cardiac autonomic neuropathy in diabetic patients
by: A. A. Belyaev, et al.
Published: (2019-03-01)

MILDRONATE THERAPY IN PATIENTS WITH CHRONIC HEART FAILURE, TYPE 2 DIABETES MELLITUS AND AUTONOMOUS CARDIAC NEUROPATHY
by: M. E. Statsenko, et al.
Published: (2009-06-01)

Screening and assessment of cardiac autonomic neuropathy in long-standing type 2 diabetic women
by: Wael Refaie
Published: (2013-01-01)

Use of α-Lipoic Acid and Benfotiamine for Correction of Disturbance of Gastric Motor-Evacuation Function in Type 1 Diabetic Patients
by: I.O. Kostitska
Published: (2015-09-01)

DIAGNOSTIC VALUE OF SPECTRAL ANALYSIS OF HEART RATE VARIABILITY IN CARDIAC AUTONOMIC NEUROPATHY AND TYPE 2 DIABETES MELLITUS
by: E. Yu. Lunina, et al.
Published: (2012-06-01)

A study of cardiac autonomic neuropathy in patients with type 2 diabetes mellitus: A Northeast India experience
by: Ashok K Bhuyan, et al.
Published: (2019-01-01)

Cardiac diabetic autonomic neuropathy
by: L. T. Akhmedzhanova, et al.
Published: (2020-01-01)

Assessment of cardiac autonomic neuropathy in long standing type 2 diabetic women
by: Wael Refaie
Published: (2014-03-01)

Autonomic neuropathy in diabetes mellitus: Clinical manifestations, diagnosis and treatment
by: A. N. Barinov, et al.
Published: (2011-06-01)

Diabetes mellitus and congestive heart failure
by: V.A. Serhiyenko, et al.
Published: (2022-03-01)

Diabetes mellitus and chronic coronary syndrome
by: V.A. Serhiyenko, et al.
Published: (2021-03-01)